After a low AMH result, the search begins almost immediately. DHEA, CoQ10, melatonin, maca root, vitamin D — fertility forums are full of anecdotal reports and supplement protocols claiming to raise AMH levels and restore ovarian reserve. When you are hoping to improve your fertility picture, these claims can feel both hopeful and confusing.
At Hanabusa IVF, we believe patients deserve honest information — not false hope or unnecessary pessimism. This article walks through what the current science actually shows about raising AMH, which supplements have been studied, and what patients with diminished ovarian reserve can realistically expect.
Why AMH Cannot Simply Be "Raised"
To understand the limits of AMH supplementation, you first need to understand what AMH measures. AMH is produced by the granulosa cells of small, developing follicles. Its level reflects the size of your remaining follicle pool — your ovarian reserve. Once follicles are lost, they are not replaced. The ovaries do not generate new eggs after birth.
No supplement can create new follicles. What some research has explored — more modestly — is whether certain interventions might support the function of existing follicles, slow the rate of reserve decline, or improve the local ovarian environment. These are different, much more limited claims than "raising AMH."
When supplement protocols appear to increase AMH in small studies, what is often observed is a modest, temporary improvement in a measured level — not a meaningful reversal of reserve depletion. The practical impact on egg quality and IVF outcomes is frequently unclear.
What the Research Says: Supplement by Supplement
DHEA (Dehydroepiandrosterone)
DHEA is the most studied supplement in the context of diminished ovarian reserve and IVF. Some trials — primarily small and non-randomized — have reported modest improvements in AMH, antral follicle count, and embryo quality in certain poor-responder patients after two to four months of supplementation.
The evidence remains mixed. Larger, well-controlled trials have not consistently confirmed these findings. DHEA also carries real risks: it can disrupt hormone balance and is contraindicated for patients with hormone-sensitive conditions. It should only be taken under direct medical supervision — not self-prescribed based on forum recommendations. At Hanabusa IVF, DHEA supplementation is discussed individually when there is a specific clinical rationale, not as a standard recommendation.
CoQ10 (Coenzyme Q10)
CoQ10 is an antioxidant that supports mitochondrial function — the cellular energy production that matters for egg development. Some animal studies and small human trials have suggested that CoQ10 may support egg quality, particularly in older patients where mitochondrial efficiency naturally declines.
The evidence for CoQ10 directly raising AMH levels is limited. Most research focuses on embryo quality and IVF outcomes rather than AMH as a specific endpoint. CoQ10 is generally considered safe at standard doses and is not objected to by most fertility specialists as part of a broader wellness approach — but it should not be presented as a proven AMH treatment.
Vitamin D
Vitamin D deficiency has been associated with poorer fertility outcomes in some studies. Correcting a documented deficiency makes clinical sense and may support overall reproductive health. However, there is limited direct evidence linking vitamin D supplementation to improved AMH levels specifically. Testing and correcting deficiency is reasonable; taking high doses without a deficiency is not supported by evidence.
Inositol
Inositol has been most extensively studied in the context of PCOS, where it appears to support insulin sensitivity and ovarian function. For patients with diminished ovarian reserve specifically, the evidence is much more limited. It is unlikely to meaningfully raise AMH in DOR patients.
Other Common Supplements
Melatonin (antioxidant, some small IVF studies), maca root (traditional, no robust clinical evidence for AMH), royal jelly (no controlled clinical evidence), and NAC (limited data) are all frequently discussed in fertility forums but none has been validated as a reliable AMH-raising intervention in large, well-designed trials.
What Actually Supports Fertility With Low AMH
While no supplement reliably reverses low AMH, several factors genuinely support reproductive health and IVF outcomes — and are worth prioritizing:
- Maintaining a healthy weight: Both obesity and very low body weight are associated with poorer egg quality and ovarian function.
- Eliminating smoking: Smoking is directly associated with accelerated ovarian aging and lower AMH — one of the most modifiable risk factors.
- Reducing alcohol consumption: Associated with poorer IVF outcomes across multiple studies.
- Managing thyroid health: Thyroid disorders can affect fertility and hormone levels independently of ovarian reserve.
- Reducing endocrine-disrupting exposures: BPA, phthalates, and similar compounds may influence ovarian function.
Hanabusa IVF offers holistic IVF support services and an acupuncture network as complementary supports for patients in treatment. These are not replacements for medical evaluation but can be meaningful additions to a comprehensive fertility plan.
The Real Risk: Losing Time
"My concern when patients come to me after months on supplements is that they may have lost time that genuinely mattered for their treatment. I want every patient to have honest information about what will actually help — so their decisions are based on evidence, not hope alone."
— Dr. Lyndon Chang, Medical Director at Hanabusa IVF
For patients with low AMH — especially those over 35 — time is a clinically significant factor. Spending several months on a supplement protocol that is unlikely to make a meaningful difference can delay the start of treatment that genuinely could. The decision about when to start treatment versus when to try a natural approach should be made with a fertility specialist, with full information about what the evidence shows.
How Hanabusa IVF Approaches Low AMH Treatment
At Hanabusa IVF, the response to a low AMH result is not a supplement recommendation — it is a comprehensive fertility evaluation that gives you the full picture of your ovarian reserve, egg supply, and realistic options. From there, an individualized protocol is designed around your specific biology.
For patients with diminished ovarian reserve, Hanabusa IVF evaluates whether Mini IVF, minimal stimulation, natural cycle IVF, or a modified conventional approach is most likely to produce viable eggs — without the overestimation of what more medication can achieve in a system with limited reserve.
"Every patient who comes to us with low AMH deserves an honest conversation about what is possible — not a list of supplements and a hope that the numbers will change. We build a plan around what is real for this patient, right now."
— Dr. Diana LeBlanc, a Fertility Specialist at Hanabusa IVF
Frequently Asked Questions About Increasing AMH
Can you increase AMH levels naturally?
There is currently no intervention proven in large clinical trials to reliably and significantly raise AMH. Some small studies suggest DHEA or CoQ10 may modestly affect levels in specific patient groups, but results are inconsistent. The most effective approach is to work with your current reserve rather than attempting to reverse it.
Can low AMH be reversed?
Low AMH reflects a reduced egg supply that cannot be restored once lost. What can be addressed are the conditions that may be accelerating decline — smoking, hormone imbalances, nutritional deficiencies. Supplements and lifestyle changes may support overall reproductive health but will not reverse established diminished ovarian reserve.
How long does it take to see AMH changes from DHEA?
Studies investigating DHEA typically run protocols of two to six months before measuring changes. Results are inconsistent across patients. For women over 35 with low AMH, spending six months on a supplement protocol before seeking fertility evaluation represents meaningful time that may affect treatment options.
Should I delay IVF while trying supplements?
For some patients — particularly younger women with AMH just below normal range — a short trial period may be reasonable. For patients over 38 with significantly low AMH, delaying IVF to try supplements typically does more harm than good. This decision should be made in direct conversation with a fertility specialist who knows your full picture.
Does Hanabusa IVF recommend supplements for low AMH?
Hanabusa IVF discusses supplement evidence honestly with each patient. CoQ10 and vitamin D correction may be appropriate in specific clinical contexts. We do not recommend protocols claiming to reverse low AMH, and we prioritize giving patients accurate information over selling hope.
Start With an Honest Evaluation — Not a Supplement Stack
If you have low AMH and are wondering what to do next, the most valuable thing you can do is get a comprehensive fertility evaluation. Understanding your complete picture — AMH, AFC, FSH, age, and response potential — is the foundation for any treatment plan that will actually help.
At Hanabusa IVF, that conversation is the starting point. Not a supplement protocol. Not a formula. A real evaluation of where your biology is and what your options actually look like.
Book Your Consultation at Hanabusa IVF




